<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39158051</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.</ArticleTitle><Pagination><StartPage>e29864</StartPage><MedlinePgn>e29864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29864</ELocationID><Abstract><AbstractText>Inflammation and autoimmune responses contribute to the pathophysiology of Long COVID, and its affective and chronic fatigue syndrome symptoms, labeled "the physio-affective phenome." To investigate whether Long COVID and its physio-affective phenome are linked to autoimmunity to the tight junction proteins, zonulin and occludin (ZOOC), and immune reactivity to lipopolysaccharides (LPS), and whether the latter are associated with signs of human herpes virus-6 (HHV-6) reactivation, autoimmunity directed against oligodendrocyte and neuronal proteins, including myelin basic protein. IgA/IgM/IgG responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), HHV-6, ZOOC, and neuronal proteins, C-reactive protein (CRP), and advanced oxidation protein products (AOPPs), were measured in 90 Long COVID patients and 90 healthy controls. The physio-affective phenome was conceptualized as a factor extracted from physical and affective symptom domains. Neural network identified IgA directed to LPS (IgA-LPS), IgG-ZOOC, IgG-LPS, and IgA-ZOOC as important variables associated with Long COVID diagnosis with an area under the ROC curve of 0.755. Partial Least Squares analysis showed that 40.9% of the variance in the physio-affective phenome was explained by CRP, IgA-myelin basic protein (MBP), and IgG-MBP. A large part of the variances in both autoimmune responses to MBP (36.3%-39.7%) was explained by autoimmunity (IgA and IgG) directed to ZOOC. The latter was strongly associated with indicants of HHV-6 reactivation, which in turn was associated with increased IgM-SARS-CoV-2. Autoimmunity against components of the tight junctions and increased bacterial translocation may be involved in the pathophysiology of Long COVID's physio-affective phenome.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center, Medical University of Plovdiv, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Innovation Program for the Development of MU-PLOVDIV-(SRIPD-MUP), Creation of a Network of Research Higher Schools, National Plan for Recovery and Sustainability, European Union-NextGenerationEU.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almulla</LastName><ForeName>Abbas F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-7667-6731</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaoou</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Psychosomatic Medicine, Chinese Academy of Medical Sciences, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoyanova</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center, Medical University of Plovdiv, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Innovation Program for the Development of MU-PLOVDIV-(SRIPD-MUP), Creation of a Network of Research Higher Schools, National Plan for Recovery and Sustainability, European Union-NextGenerationEU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vojdani</LastName><ForeName>Aristo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunosciences Lab Inc., Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cyrex Laboratories, LLC, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HEA663000016</GrantID><Agency>Thailand Science Research, and Innovation Fund</Agency><Country/></Grant><Grant><GrantID>64.310/436/2565</GrantID><Agency>Chulalongkorn University</Agency><Country/></Grant><Grant><GrantID>RA66/016</GrantID><Agency>Sompoch Endowment Fund (Faculty of Medicine) MDCU</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C408043">zonulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062793">Occludin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568985">OCLN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006242">Haptoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015654" MajorTopicYN="Y">Herpesvirus 6, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019108" MajorTopicYN="Y">Tight Junctions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="Y">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062793" MajorTopicYN="N">Occludin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019349" MajorTopicYN="N">Roseolovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006242" MajorTopicYN="N">Haptoglobins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">affective disorders</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">neuroimmune</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>19</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>19</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>19</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39158051</ArticleId><ArticleId IdType="doi">10.1002/jmv.29864</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2010;146.</Citation></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long&#x2010;term neurological and neuropsychiatric manifestations of post&#x2010;COVID&#x2010;19 syndrome: a meta&#x2010;analysis. J Neurol Sci. 2022;434:120162.</Citation></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144.</Citation></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short&#x2010;term and long&#x2010;term rates of postacute sequelae of SARS&#x2010;CoV&#x2010;2 infection: a systematic review. JAMA Network Open. 2021;4(10):e2128568.</Citation></Reference><Reference><Citation>Stefanou M&#x2010;I, Palaiodimou L, Bakola E, et al. Neurological manifestations of long&#x2010;COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:204062232210768.</Citation></Reference><Reference><Citation>Al&#x2010;Hakeim HK, Al&#x2010;Rubaye HT, Almulla AF, Al&#x2010;Hadrawi DS, Maes M. Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by neuroimmune and neuro&#x2010;oxidative pathways which are caused by the inflammation during acute infection. J Clin Med. 2023;12(2):511.</Citation></Reference><Reference><Citation>Al&#x2010;Hakeim HK, Al&#x2010;Rubaye HT, Al&#x2010;Hadrawi DS, Almulla AF, Maes M. Long&#x2010;COVID post&#x2010;viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry. 2023;28(2):564&#x2010;578.</Citation></Reference><Reference><Citation>Maes M, Al&#x2010;Rubaye HT, Almulla AF, et al. Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation and neuroimmunotoxic pathways. Int J Environ Res Public Health. 2022;19(16):10362.</Citation></Reference><Reference><Citation>Al&#x2010;Hadrawi DS, Al&#x2010;Rubaye HT, Almulla AF, Al&#x2010;Hakeim HK, Maes M. Lowered oxygen saturation and increased body temperature in acute COVID&#x2010;19 largely predict chronic fatigue syndrome and affective symptoms due to long COVID: a precision nomothetic approach. Acta Neuropsychiatrica. 2023;35(2):76&#x2010;87.</Citation></Reference><Reference><Citation>Al&#x2010;Jassas HK, Al&#x2010;Hakeim HK, Maes M. Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome&#x2010;like symptoms due to COVID&#x2010;19: a nomothetic network approach. J Affect Disord. 2022;297:233&#x2010;245.</Citation></Reference><Reference><Citation>Al&#x2010;Hakeim HK, Khairi Abed A, Rouf Moustafa S, Almulla AF, Maes M. Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID. Front Mol Neurosci. 2023;16:1194769.</Citation></Reference><Reference><Citation>Al&#x2010;Hakeim HK, Abed AK, Almulla AF, Rouf Moustafa S, Maes M. Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway. Asian Journal of Psychiatry. 2023;88:103723.</Citation></Reference><Reference><Citation>Abbas FA, Yanin T, Bo Z, Aristo V, Michael M Immune activation and immune&#x2010;associated neurotoxicity in Long&#x2010;COVID: A systematic review and meta&#x2010;analysis of 82 studies comprising 58 cytokines/chemokines/growth factors. medRxiv. 2024: 2024.2002.2008.24302516.</Citation></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, et al. Inflammatory and vascular biomarkers in post&#x2010;COVID&#x2010;19 syndrome: a systematic review and meta&#x2010;analysis of over 20 biomarkers. Rev Med Virol. 2023;33(2):e2424.</Citation></Reference><Reference><Citation>Vojdani A, Almulla AF, Zhou B, Al&#x2010;Hakeim HK, Maes M. Reactivation of herpesvirus type 6 and IgA/IgM&#x2010;mediated responses to activin&#x2010;A underpin Long COVID, including affective symptoms and chronic fatigue syndrome. Acta Neuropsychiatrica. 2024;36:172&#x2010;184.</Citation></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS&#x2010;CoV&#x2010;2 infection, EBV, HHV&#x2010;6 and other factors May contribute to inflammation and autoimmunity in Long COVID. Viruses. 2023;15(2):400.</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post&#x2010;acute COVID&#x2010;19 sequelae. Cell. 2022;185(5):881&#x2010;895.e20. e820.</Citation></Reference><Reference><Citation>Almulla AF, Maes M, Bo Z, Hussein KA&#x2010;H, Aristo V. Brain&#x2010;Targeted Autoimmunity Is Strongly Associated With Long Covid and Its Chronic Fatigue Syndrome as Well as Its Affective Symptoms. medRxiv. 2023.</Citation></Reference><Reference><Citation>Morris G, Maes M. Oxidative and nitrosative stress and Immune&#x2010;Inflammatory pathways in patients with myalgic encephalomyelitis (ME)/Chronic fatigue syndrome (CFS). Curr Neuropharmacol. 2014;12(2):168&#x2010;185.</Citation></Reference><Reference><Citation>Morris G, Maes M. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med. 2013;11(1):205.</Citation></Reference><Reference><Citation>Maes M, Carvalho AF. The compensatory immune&#x2010;regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol. 2018;55(12):8885&#x2010;8903.</Citation></Reference><Reference><Citation>Almulla AF, Abbas Abo Algon A, Tunvirachaisakul C, Al&#x2010;Hakeim HK, Maes M. T helper&#x2010;1 activation via interleukin&#x2010;16 is a key phenomenon in the acute phase of severe, first&#x2010;episode major depressive disorder and suicidal behaviors. J Adv Res. 2023;13:S2090&#x2010;1232.</Citation></Reference><Reference><Citation>Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram&#x2010;negative enterobacteria in the etiology of CFS and for the presence of an increased gut&#x2010;intestinal permeability. J Affect Disord. 2007;99(1&#x2010;3):237&#x2010;240.</Citation></Reference><Reference><Citation>Maes M, Kubera M, Leunis JC. The gut&#x2010;brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29(1):117&#x2010;124.</Citation></Reference><Reference><Citation>Simeonova D, Stoyanov D, Leunis JC, et al. Increased serum immunoglobulin responses to gut commensal Gram&#x2010;Negative bacteria in unipolar major depression and bipolar disorder type 1, especially when melancholia is present. Neurotoxic Res. 2020;37(2):338&#x2010;348.</Citation></Reference><Reference><Citation>Simeonova D, Ivanovska M, Murdjeva M, Carvalho AF, Maes M. Recognizing the leaky gut as a trans&#x2010;diagnostic target for neuroimmune disorders using clinical chemistry and molecular immunology assays. Curr Top Med Chem. 2018;18(19):1641&#x2010;1655.</Citation></Reference><Reference><Citation>Ohlsson L, Gustafsson A, Lavant E, et al. Leaky gut biomarkers in depression and suicidal behavior. Acta Psychiatr Scand. 2019;139(2):185&#x2010;193.</Citation></Reference><Reference><Citation>Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&amp;NS), and autoimmune responses directed against O&amp;NS&#x2010;damaged neoepitopes. Acta Psychiatr Scand. 2013;127(5):344&#x2010;354.</Citation></Reference><Reference><Citation>Rudzki L, Maes M. The Microbiota&#x2010;Gut&#x2010;Immune&#x2010;Glia (MGIG) axis in major depression. Mol Neurobiol. 2020;57(10):4269&#x2010;4295.</Citation></Reference><Reference><Citation>Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol. 2017;23(31):5669&#x2010;5679.</Citation></Reference><Reference><Citation>Vojdani A, Vojdani E. Food&#x2010;associated autoimmunities: when food breaks your immune system. A&amp;G Press; 2019.</Citation></Reference><Reference><Citation>Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012;10(10):1096&#x2010;1100.</Citation></Reference><Reference><Citation>Halme L, Arola J, Hockerstedt K, Lautenschlager I. Human herpesvirus 6 infection of the gastroduodenal mucosa. Clin Infect Dis. 2008;46(3):434&#x2010;439.</Citation></Reference><Reference><Citation>Amo K, Tanaka&#x2010;Taya K, Inagi R, et al. Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis. 2003;36(1):120&#x2010;123.</Citation></Reference><Reference><Citation>World Health Organization W. A Clinical Case Definition of Post COVID&#x2010;19 Condition by a Delphi Consensus 6 October. WHO. 2021.</Citation></Reference><Reference><Citation>Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50&#x2010;55.</Citation></Reference><Reference><Citation>Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery &amp; Psychiatry. 1960;23(1):56&#x2010;62.</Citation></Reference><Reference><Citation>Hautzinger MKFKhCBATSRABGK. Beck Depressions&#x2010;Inventar: BDI&#x2010;II; Revision; Manual. Pearson; 2009.</Citation></Reference><Reference><Citation>Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG. A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res. 2002;52(6):501&#x2010;509.</Citation></Reference><Reference><Citation>Madison AA, Andridge R, Kantaras AH, et al. Depression, inflammation, and intestinal permeability: associations with subjective and objective cognitive functioning throughout breast cancer survivorship. Cancers. 2023;15(17):4414.</Citation></Reference><Reference><Citation>Iordache MM, Tocia C, Aschie M, et al. Intestinal permeability and depression in patients with inflammatory bowel disease. J Clin Med. 2022;11(17):5121.</Citation></Reference><Reference><Citation>Maes M, Vasupanrajit A, Jirakran K, et al. Adverse childhood experiences and reoccurrence of illness impact the gut microbiome, which affects suicidal behaviours and the phenome of major depression: towards enterotypic phenotypes. Acta Neuropsychiatrica. 2023;35(6):328&#x2010;345.</Citation></Reference><Reference><Citation>Stallmach A, Quickert S, Puta C, Reuken PA. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives. Front Immunol. 2024;15:1352744.</Citation></Reference><Reference><Citation>Wang JH, Choi Y, Lee JS, Hwang SJ, Gu J, Son CG. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review. Eur J Med Res. 2024;29(1):148.</Citation></Reference><Reference><Citation>Chen CY, Wang YF, Lei L, Zhang Y. Impacts of microbiota and its metabolites through gut&#x2010;brain axis on pathophysiology of major depressive disorder. Life Sci. 2024;351:122815.</Citation></Reference><Reference><Citation>Tao K, Yuan Y, Xie Q, Dong Z. Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: an updated overview. Behav Brain Res. 2024;471:115111.</Citation></Reference><Reference><Citation>Palomino&#x2010;Kobayashi LA, Yma&#xf1;a B, Ruiz J, et al. Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised Peruvian COVID&#x2010;19 patients. Front Cell Infect Microbiol. 2022;12:1000291.</Citation></Reference><Reference><Citation>Ghoshal UC, Ghoshal U. Gastrointestinal involvement in post&#x2010;acute coronavirus disease (COVID)&#x2010;19 syndrome. Curr Opin Infect Dis. 2023;36(5):366&#x2010;370.</Citation></Reference><Reference><Citation>Li Z, Xia Q, Feng J, et al. The causal role of gut microbiota in susceptibility of Long COVID: a Mendelian randomization study. Front Microbiol. 2024;15:1404673.</Citation></Reference><Reference><Citation>Su Q, Lau RI, Liu Q, et al. The gut microbiome associates with phenotypic manifestations of post&#x2010;acute COVID&#x2010;19 syndrome. Cell Host Microbe. 2024;32(5):651&#x2010;660.e4.</Citation></Reference><Reference><Citation>Mussabay K, Kozhakhmetov S, Dusmagambetov M, et al. Gut microbiome and cytokine profiles in post&#x2010;COVID syndrome. Viruses. 2024;16(5):722.</Citation></Reference><Reference><Citation>Hern&#xe1;ndez&#x2010;Parra H, Reyes&#x2010;Hern&#xe1;ndez OD, Figueroa&#x2010;Gonz&#xe1;lez G, et al. Alteration of the blood&#x2010;brain barrier by COVID&#x2010;19 and its implication in the permeation of drugs into the brain. Front Cell Neurosci. 2023;17:1125109.</Citation></Reference><Reference><Citation>Krasemann S, Haferkamp U, Pfefferle S, et al. The blood&#x2010;brain barrier is dysregulated in COVID&#x2010;19 and serves as a CNS entry route for SARS&#x2010;CoV&#x2010;2. Stem Cell Reports. 2022;17(2):307&#x2010;320.</Citation></Reference><Reference><Citation>Aceti A, Margarucci LM, Scaramucci E, et al. Serum S100B protein as a marker of severity in Covid&#x2010;19 patients. Sci Rep. 2020;10(1):18665.</Citation></Reference><Reference><Citation>Fonseca DLM, Filgueiras IS, Marques AHC, et al. Severe COVID&#x2010;19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach. npj Aging. 2023;9(1):21.</Citation></Reference><Reference><Citation>Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood&#x2010;brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 2012;18(8):609&#x2010;615.</Citation></Reference><Reference><Citation>Stuart CM, Varatharaj A, Winberg ME, et al. Zonulin and blood&#x2010;brain barrier permeability are dissociated in humans. Clin Transl Med. 2022;12(7):e965.</Citation></Reference><Reference><Citation>Nahar S, Hokama A, Fujita J. Clinical significance of cytomegalovirus and other herpes virus infections in ulcerative colitis. Pol Arch Med Wewn. 2019;129(9):620&#x2010;626.</Citation></Reference><Reference><Citation>Nahar S. Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis. World J Gastroenterol. 2015;21(44):12667&#x2010;12675.</Citation></Reference><Reference><Citation>Mousset S, Martin H, Berger A, et al. Human herpesvirus 6 in biopsies from patients with gastrointestinal symptoms after allogeneic stem cell transplantation. Ann Hematol. 2012;91(5):737&#x2010;742.</Citation></Reference><Reference><Citation>Maes M, Ringel K, Kubera M, et al. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5&#x2010;HT is associated with immuno&#x2010;inflammatory pathways and bacterial translocation. J Affect Disord. 2013;150(2):223&#x2010;230.</Citation></Reference><Reference><Citation>Maes M, Simeonova D, Stoyanov D, Leunis JC. Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depression, but not BP2: increased IgM antibodies to nitrosylated conjugates are associated with indicants of leaky gut. Nitric Oxide. 2019;91:67&#x2010;76.</Citation></Reference><Reference><Citation>English J, Connolly L, Stewart LD. Increased intestinal permeability: an avenue for the development of autoimmune disease? Expos Health. 2024;16(2):575&#x2010;605.</Citation></Reference><Reference><Citation>Thisayakorn P, Thipakorn Y, Tantavisut S, Sirivichayakul S, Vojdani A, Maes M. Increased IgA&#x2010;mediated responses to the gut paracellular pathway and blood&#x2010;brain barrier proteins predict delirium due to hip fracture in older adults. Front Neurol. 2024;15:1294689.</Citation></Reference><Reference><Citation>Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42(1):102&#x2010;111.</Citation></Reference><Reference><Citation>Oldstone MBA. Molecular mimicry and autoimmune disease. Cell. 1987;50(6):819&#x2010;820.</Citation></Reference><Reference><Citation>McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 1995;182(1):75&#x2010;85.</Citation></Reference><Reference><Citation>Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci. 1983;80(8):2346&#x2010;2350.</Citation></Reference><Reference><Citation>Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 1993;9:101&#x2010;128.</Citation></Reference><Reference><Citation>Maes M, Leunis JC. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram&#x2010;negative bacteria. Neuro Endocrinol Lett. 2008;29(6):902&#x2010;910.</Citation></Reference><Reference><Citation>Zhang D, Zhou Y, Ma Y, et al. Gut microbiota dysbiosis correlates with long COVID&#x2010;19 at One&#x2010;Year after discharge. J Korean Med Sci. 2023;38(15):e120.</Citation></Reference><Reference><Citation>Anderson G, Reiter RJ. Melatonin: roles in influenza, Covid&#x2010;19, and other viral infections. Rev Med Virol. 2020;30(3):e2109.</Citation></Reference><Reference><Citation>Luu M, Weigand K, Wedi F, et al. Regulation of the effector function of CD8+ T cells by gut microbiota&#x2010;derived metabolite butyrate. Sci Rep. 2018;8(1):14430.</Citation></Reference><Reference><Citation>Anderson G, Maes M. Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications. Curr Top Med Chem. 2020;20(7):524&#x2010;539.</Citation></Reference><Reference><Citation>El&#x2010;Mayet FS, Santos VC, Wijesekera N, et al. Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic mithramycin A, stimulates human alphaherpesvirus 1 (HSV&#x2010;1) replication. Antiviral Res. 2024;225:105870.</Citation></Reference><Reference><Citation>Vivoli R, Rovesti S, Borella P, Cermelli C. Relation between psychoneuroendocrine profile in stressful conditions and antibodies to herpesvirus 6 and 7. J Biol Regul Homeost Agents. 2008;22(4):239&#x2010;245.</Citation></Reference><Reference><Citation>Zhu K, Zhang Y, Zhang J, et al. Acetylation of Hsp90 reverses dexamethasone&#x2010;mediated inhibition of insulin secretion. Toxicol Lett. 2020;320:19&#x2010;27.</Citation></Reference><Reference><Citation>Shukla PK, Meena AS, Pierre JF, Rao R. Central role of intestinal epithelial glucocorticoid receptor in alcohol&#x2010; and corticosterone&#x2010;induced gut permeability and systemic response. FASEB J. 2022;36(1):e22061.</Citation></Reference><Reference><Citation>Politikos I, McMasters M, Bryke C, Avigan D, Boussiotis VA. Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor. Blood Adv. 2018;2(12):1367&#x2010;1370.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>